IN B00001
Alternative Names: IN-B00001; IN-B002Latest Information Update: 07 Jan 2025
At a glance
- Originator HK inno.N
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Smallpox
Highest Development Phases
- Phase I Smallpox
Most Recent Events
- 07 Jan 2025 Phase-I clinical trials in Smallpox (Prevention) (Parenteral), prior to January 2025 (HK inno.N pipeline, January 2025)
- 29 Mar 2024 Preclinical development in Smallpox (Prevention) is ongoing in South Korea (unspecified route) prior to March 2024 (HK inno.N pipeline, March 2024)
- 28 Feb 2024 No recent reports of development identified for preclinical development in Smallpox(Prevention) in South Korea